Sequence plasticity in the antigen-binding site of a therapeutic anti-HER2 antibody
Sequence plasticity in the antigen-binding site of a therapeutic anti-HER2 antibody
复制标题
DOI:
10.1016/s0022-2836(02)00677-0
复制
发表时间:
2002-08-30
影响因子:
5.6
通讯作者:
Lowman, HB
中科院分区:
文献类型:
--
作者:
Gerstner, RB;Carter, P;Lowman, HB
We have examined the plasticity of the antigen-combining site of a high-affinity antibody In phage-displayed Fab libraries, selected CDR positions and one FR position of the humanized anti-Her2 antibody hu4D5 were substituted with all 20 amino acids. Antigen-binding selections were used to enrich for high-affinity variants, and a large number of sequences were obtained prior to convergence of the selected pool to a small set of clones. As expected, sequence variability of the antigen-binding site is overall diminished compared to known IgG sequences; however, certain positions retain much higher variability than others. The sequence variability map of the hu4D5 binding site is compared with a map derived from previous alanine-scanning of the antibody. Affinities of soluble Fab fragments for antigen confirm that multiple variants were selected with high affinity for antigen, including one variant with a single point mutation that was about threefold improved in affinity compared to the parental hu4D5. Interestingly, this mutation is one of the most radical in terms of changing side-chain chemistry (Trp for Asp) and occurs at the most plastic site as calculated by the Wu-Kabat variability coefficient. Thus variability mapping yields information about the antibody-antigen interaction that is useful and complementary to that obtained by alanine scanning mutagenesis. (C) 2002 Elsevier Science Ltd. All rights reserved.